Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Ronglin Kan"'
Autor:
Liangxiao Wang, Chunjie Sha, Yawen Yu, Liuxiang Chu, Kaoxiang Sun, Aiping Wang, Ronglin Kan, Junping Han, Xinran Xi
Publikováno v:
Journal of Pharmaceutical Sciences. 110:3431-3438
Temozolomide is a first-line therapeutic drug for glioblastoma (GBM), and it has a low solubility, short biological half-life, and resistance to drug limits in clinical applications. Therefore, it is necessary to find more effective anti-tumor drugs